Mednet Logo

How would you treat a newly diagnosed male with metastatic HR+ breast cancer?

Do you give first-line CDK 4/6 inhibitors with Tamoxifen or Aromatase Inhibitor (+/- GnRH analog)?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Cedars-Sinai Medical Center
Answered on

I would recommend CDK 4/6 with AI and GnRH analog.

There's no clear evidence from studies since male breast cancer is rare (<1% of breast cancers), and most CDK studies did not include male patients. One case report was published recently by Hansra et al., PMID 31929882.

FDA-approved palbociclib for m...

Join for free or sign in to see the full answer